Safety of MVA-BN in Healthcare Personnel, Democratic Republic of the Congo
Faisal S. Minhaj(The Centers), Andrea M. McCollum(Centers for Disease Control and Prevention), Stephanie Tran(Centers for Disease Control and Prevention), Mary G. Reynolds(Centers for Disease Control and Prevention), Agam K. Rao, Jordan L. Kennedy(Centers for Disease Control and Prevention), Didine Kaba(University of Kinshasa), Benjamin Monroe, Michael B. Townsend(Centers for Disease Control and Prevention), Christine M. Hughes(Centers for Disease Control and Prevention), Patricia Yu(Centers for Disease Control and Prevention), Béatrice Nguete(University of Kinshasa), Gaston Kokola(Ministry of Public Health), Joelle Kabamba(Centers for Disease Control and Prevention), Marissa K. Person(Centers for Disease Control and Prevention), Robert Shongo Lushima(Ministry of Public Health), Anna Mandra(Centers for Disease Control and Prevention), Yon Yu(Department of Human Services), Toutou Likafi(Ministry of Public Health), Dorah Kasongo(Ministry of Public Health), Brett W. Petersen(Centers for Disease Control and Prevention)
Cited by 0
Related Papers
Cancer nanomedicine: a review of recent success in drug delivery
|Clinical and Translational Medicine|2017|918
Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
|Nature Medicine|2024|350
Monkeypox Outbreak — Nine States, May 2022
|MMWR Morbidity and Mortality Weekly Report|2022|309
Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021
|MMWR Morbidity and Mortality Weekly Report|2022|277